SLC5A2 and heart failure: Although various hypotheses have been proposed as mechanisms of the improvement of CV outcomes by treatment with SGLT2 inhibitors [3,33], osmotic diuresis due to glucosuria likely plays a major role that reduces cardiac preload and thereby reducing the incidence of heart failure and arrythmia, resulting in the reduction in CV death (Figure 1).